世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
口腔液と唾液による薬物検査の世界市場成長 2024-2030Global Oral Fluid and Saliva Drug Testing Market Growth 2024-2030 口腔液および唾液薬物検査は、人の唾液中の薬物またはその代謝物の存在を検出するために使用される方法である。これらの検査は、非侵襲的な性質と投与の容易さから、職場、法執行機関、臨床環境など様々な環境で... もっと見る
日本語のページは自動翻訳を利用し作成しています。 
サマリー口腔液および唾液薬物検査は、人の唾液中の薬物またはその代謝物の存在を検出するために使用される方法である。これらの検査は、非侵襲的な性質と投与の容易さから、職場、法執行機関、臨床環境など様々な環境で一般的に使用されています。世界の口腔液・唾液薬物検査市場規模は、2024年の100万米ドルから2030年には100万米ドルに成長すると予測され、2024年から2030年までの年平均成長率は%で推移すると予測されています。 LPインフォメーション株式会社（東京都港区、代表取締役：劉克振）の最新調査レポート「経口液と唾液による薬物検査産業の予測」は、過去の売上高と2023年の経口液と唾液による薬物検査の世界総売上高に注目し、2024年から2030年に予測される経口液と唾液による薬物検査の売上高を地域別・市場分野別に包括的に分析しています。経口液および唾液薬物検査の売上高を地域別、市場分野別、サブセクター別に分類し、世界の経口液および唾液薬物検査産業の詳細な分析を百万米ドル単位で提供します。 このインサイトレポートでは、世界の経口液・唾液薬物検査業界を包括的に分析し、製品区分、企業形成、収益、市場シェア、最新動向、M&A活動に関する主要動向を明らかにします。また、本レポートでは、加速する世界の経口液・唾液薬物検査市場におけるこれらの企業の独自のポジションをよりよく理解するために、経口液・唾液薬物検査のポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、主要グローバル企業の戦略を分析しています。 本インサイトレポートでは、経口液・唾液薬物検査の世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を細分化して、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの定性的・定量的市場インプットに基づいた透明性の高い手法により、この調査予測は世界の経口液・唾液薬物検査の現状と将来の軌道について非常にニュアンスのある見解を提供します。 経口液・唾液薬物検査の米国市場は、2023年の100万米ドルから2030年までに100万米ドルに増加し、2024年から2030年までの年平均成長率は％と推定される。 経口液・唾液薬物検査の中国市場は、2023年の100万米ドルから2030年には100万米ドルに、2024年から2030年までの年平均成長率は％で増加すると推定される。 経口液・唾液薬物検査のヨーロッパ市場は、2023年の100万米ドルから2030年には100万米ドルに、2024年から2030年までの年平均成長率は％で増加すると推定される。 経口液および唾液薬物検査の世界の主要企業は、Abbott、Premier Biotech、OraSure Technologies、MHE、VeriCheckなどです。売上高では、世界の2大企業が2023年にほぼ％のシェアを占めている。 のシェアを占めています。 本レポートでは、製品タイプ別、用途別、主要メーカー別、主要地域別および国別の口腔液および唾液薬物検査市場の包括的な概要、市場シェア、成長機会を紹介します。 タイプ別セグメント 5パネル以下 5パネル-10パネル 10パネル以上 用途別セグメント 刑事司法検査 職場検査 リハビリ療法 スポーツ競技 その他 本レポートはまた、市場を地域別に分けています： 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 アボット プレミアバイオテック オラシュア・テクノロジーズ MHE ベリチェック ウルチメッド・プロダクツ（ドイツ） ヒールゲン・サイエンティフィック アルコライザー ケアヘルスアメリカ アルファバイオラボ アルコデジタル アゾバ ドラッガー Securetec Detektions-Systeme クエスト・ダイアグノスティックス オラノクシス サリメトリクス ネオジェン・コーポレーション UCPバイオサイエンス 林志国際 メダックス メディナット WHPM アキュバイオテック アシュアテック ウェルバイオテック 本レポートで扱う主な質問 世界の経口液および唾液薬物検査市場の10年展望は？ 世界および地域別に、どのような要因が口腔液および唾液薬物検査市場の成長を促進しているのか？ 市場別、地域別に最も急成長する技術は何か？ 内服液および唾液薬物検査の市場機会は最終市場規模によってどのように異なるのか？ 経口液および唾液薬物検査のタイプ別、用途別の内訳は？ 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Oral Fluid and Saliva Drug Testing Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Oral Fluid and Saliva Drug Testing by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Oral Fluid and Saliva Drug Testing by Country/Region, 2019, 2023 & 2030 2.2 Oral Fluid and Saliva Drug Testing Segment by Type 2.2.1 5 Panels or Less 2.2.2 5 Panel-10 Panel 2.2.3 10 Panels or Above 2.3 Oral Fluid and Saliva Drug Testing Sales by Type 2.3.1 Global Oral Fluid and Saliva Drug Testing Sales Market Share by Type (2019-2024) 2.3.2 Global Oral Fluid and Saliva Drug Testing Revenue and Market Share by Type (2019-2024) 2.3.3 Global Oral Fluid and Saliva Drug Testing Sale Price by Type (2019-2024) 2.4 Oral Fluid and Saliva Drug Testing Segment by Application 2.4.1 Criminal Justice Testing 2.4.2 Workplace Testing 2.4.3 Rehabilitation Therapy 2.4.4 Sports Competition 2.4.5 Others 2.5 Oral Fluid and Saliva Drug Testing Sales by Application 2.5.1 Global Oral Fluid and Saliva Drug Testing Sale Market Share by Application (2019-2024) 2.5.2 Global Oral Fluid and Saliva Drug Testing Revenue and Market Share by Application (2019-2024) 2.5.3 Global Oral Fluid and Saliva Drug Testing Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global Oral Fluid and Saliva Drug Testing Breakdown Data by Company 3.1.1 Global Oral Fluid and Saliva Drug Testing Annual Sales by Company (2019-2024) 3.1.2 Global Oral Fluid and Saliva Drug Testing Sales Market Share by Company (2019-2024) 3.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue by Company (2019-2024) 3.2.1 Global Oral Fluid and Saliva Drug Testing Revenue by Company (2019-2024) 3.2.2 Global Oral Fluid and Saliva Drug Testing Revenue Market Share by Company (2019-2024) 3.3 Global Oral Fluid and Saliva Drug Testing Sale Price by Company 3.4 Key Manufacturers Oral Fluid and Saliva Drug Testing Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Oral Fluid and Saliva Drug Testing Product Location Distribution 3.4.2 Players Oral Fluid and Saliva Drug Testing Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Oral Fluid and Saliva Drug Testing by Geographic Region 4.1 World Historic Oral Fluid and Saliva Drug Testing Market Size by Geographic Region (2019-2024) 4.1.1 Global Oral Fluid and Saliva Drug Testing Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Oral Fluid and Saliva Drug Testing Market Size by Country/Region (2019-2024) 4.2.1 Global Oral Fluid and Saliva Drug Testing Annual Sales by Country/Region (2019-2024) 4.2.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue by Country/Region (2019-2024) 4.3 Americas Oral Fluid and Saliva Drug Testing Sales Growth 4.4 APAC Oral Fluid and Saliva Drug Testing Sales Growth 4.5 Europe Oral Fluid and Saliva Drug Testing Sales Growth 4.6 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales Growth 5 Americas 5.1 Americas Oral Fluid and Saliva Drug Testing Sales by Country 5.1.1 Americas Oral Fluid and Saliva Drug Testing Sales by Country (2019-2024) 5.1.2 Americas Oral Fluid and Saliva Drug Testing Revenue by Country (2019-2024) 5.2 Americas Oral Fluid and Saliva Drug Testing Sales by Type (2019-2024) 5.3 Americas Oral Fluid and Saliva Drug Testing Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Oral Fluid and Saliva Drug Testing Sales by Region 6.1.1 APAC Oral Fluid and Saliva Drug Testing Sales by Region (2019-2024) 6.1.2 APAC Oral Fluid and Saliva Drug Testing Revenue by Region (2019-2024) 6.2 APAC Oral Fluid and Saliva Drug Testing Sales by Type (2019-2024) 6.3 APAC Oral Fluid and Saliva Drug Testing Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Oral Fluid and Saliva Drug Testing by Country 7.1.1 Europe Oral Fluid and Saliva Drug Testing Sales by Country (2019-2024) 7.1.2 Europe Oral Fluid and Saliva Drug Testing Revenue by Country (2019-2024) 7.2 Europe Oral Fluid and Saliva Drug Testing Sales by Type (2019-2024) 7.3 Europe Oral Fluid and Saliva Drug Testing Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Oral Fluid and Saliva Drug Testing by Country 8.1.1 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Country (2019-2024) 8.1.2 Middle East & Africa Oral Fluid and Saliva Drug Testing Revenue by Country (2019-2024) 8.2 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Type (2019-2024) 8.3 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Oral Fluid and Saliva Drug Testing 10.3 Manufacturing Process Analysis of Oral Fluid and Saliva Drug Testing 10.4 Industry Chain Structure of Oral Fluid and Saliva Drug Testing 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Oral Fluid and Saliva Drug Testing Distributors 11.3 Oral Fluid and Saliva Drug Testing Customer 12 World Forecast Review for Oral Fluid and Saliva Drug Testing by Geographic Region 12.1 Global Oral Fluid and Saliva Drug Testing Market Size Forecast by Region 12.1.1 Global Oral Fluid and Saliva Drug Testing Forecast by Region (2025-2030) 12.1.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global Oral Fluid and Saliva Drug Testing Forecast by Type (2025-2030) 12.7 Global Oral Fluid and Saliva Drug Testing Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 Abbott 13.1.1 Abbott Company Information 13.1.2 Abbott Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.1.3 Abbott Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Abbott Main Business Overview 13.1.5 Abbott Latest Developments 13.2 Premier Biotech 13.2.1 Premier Biotech Company Information 13.2.2 Premier Biotech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.2.3 Premier Biotech Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 Premier Biotech Main Business Overview 13.2.5 Premier Biotech Latest Developments 13.3 OraSure Technologies 13.3.1 OraSure Technologies Company Information 13.3.2 OraSure Technologies Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.3.3 OraSure Technologies Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 OraSure Technologies Main Business Overview 13.3.5 OraSure Technologies Latest Developments 13.4 MHE 13.4.1 MHE Company Information 13.4.2 MHE Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.4.3 MHE Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 MHE Main Business Overview 13.4.5 MHE Latest Developments 13.5 VeriCheck 13.5.1 VeriCheck Company Information 13.5.2 VeriCheck Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.5.3 VeriCheck Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 VeriCheck Main Business Overview 13.5.5 VeriCheck Latest Developments 13.6 ulti med Products (Deutschland) 13.6.1 ulti med Products (Deutschland) Company Information 13.6.2 ulti med Products (Deutschland) Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.6.3 ulti med Products (Deutschland) Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 ulti med Products (Deutschland) Main Business Overview 13.6.5 ulti med Products (Deutschland) Latest Developments 13.7 Healgen Scientific 13.7.1 Healgen Scientific Company Information 13.7.2 Healgen Scientific Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.7.3 Healgen Scientific Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Healgen Scientific Main Business Overview 13.7.5 Healgen Scientific Latest Developments 13.8 Alcolizer 13.8.1 Alcolizer Company Information 13.8.2 Alcolizer Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.8.3 Alcolizer Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Alcolizer Main Business Overview 13.8.5 Alcolizer Latest Developments 13.9 CareHealth America 13.9.1 CareHealth America Company Information 13.9.2 CareHealth America Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.9.3 CareHealth America Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 CareHealth America Main Business Overview 13.9.5 CareHealth America Latest Developments 13.10 AlphaBiolabs 13.10.1 AlphaBiolabs Company Information 13.10.2 AlphaBiolabs Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.10.3 AlphaBiolabs Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 AlphaBiolabs Main Business Overview 13.10.5 AlphaBiolabs Latest Developments 13.11 AlcoDigital 13.11.1 AlcoDigital Company Information 13.11.2 AlcoDigital Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.11.3 AlcoDigital Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 AlcoDigital Main Business Overview 13.11.5 AlcoDigital Latest Developments 13.12 Azova 13.12.1 Azova Company Information 13.12.2 Azova Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.12.3 Azova Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.12.4 Azova Main Business Overview 13.12.5 Azova Latest Developments 13.13 Draeger 13.13.1 Draeger Company Information 13.13.2 Draeger Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.13.3 Draeger Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.13.4 Draeger Main Business Overview 13.13.5 Draeger Latest Developments 13.14 Securetec Detektions-Systeme 13.14.1 Securetec Detektions-Systeme Company Information 13.14.2 Securetec Detektions-Systeme Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.14.3 Securetec Detektions-Systeme Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.14.4 Securetec Detektions-Systeme Main Business Overview 13.14.5 Securetec Detektions-Systeme Latest Developments 13.15 Quest Diagnostics 13.15.1 Quest Diagnostics Company Information 13.15.2 Quest Diagnostics Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.15.3 Quest Diagnostics Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.15.4 Quest Diagnostics Main Business Overview 13.15.5 Quest Diagnostics Latest Developments 13.16 Oranoxis 13.16.1 Oranoxis Company Information 13.16.2 Oranoxis Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.16.3 Oranoxis Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.16.4 Oranoxis Main Business Overview 13.16.5 Oranoxis Latest Developments 13.17 Salimetrics 13.17.1 Salimetrics Company Information 13.17.2 Salimetrics Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.17.3 Salimetrics Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.17.4 Salimetrics Main Business Overview 13.17.5 Salimetrics Latest Developments 13.18 Neogen Corporation 13.18.1 Neogen Corporation Company Information 13.18.2 Neogen Corporation Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.18.3 Neogen Corporation Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.18.4 Neogen Corporation Main Business Overview 13.18.5 Neogen Corporation Latest Developments 13.19 UCP Biosciences 13.19.1 UCP Biosciences Company Information 13.19.2 UCP Biosciences Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.19.3 UCP Biosciences Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.19.4 UCP Biosciences Main Business Overview 13.19.5 UCP Biosciences Latest Developments 13.20 Lin-Zhi International 13.20.1 Lin-Zhi International Company Information 13.20.2 Lin-Zhi International Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.20.3 Lin-Zhi International Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.20.4 Lin-Zhi International Main Business Overview 13.20.5 Lin-Zhi International Latest Developments 13.21 MEDACX 13.21.1 MEDACX Company Information 13.21.2 MEDACX Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.21.3 MEDACX Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.21.4 MEDACX Main Business Overview 13.21.5 MEDACX Latest Developments 13.22 MediNat 13.22.1 MediNat Company Information 13.22.2 MediNat Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.22.3 MediNat Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.22.4 MediNat Main Business Overview 13.22.5 MediNat Latest Developments 13.23 WHPM 13.23.1 WHPM Company Information 13.23.2 WHPM Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.23.3 WHPM Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.23.4 WHPM Main Business Overview 13.23.5 WHPM Latest Developments 13.24 AccuBioTech 13.24.1 AccuBioTech Company Information 13.24.2 AccuBioTech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.24.3 AccuBioTech Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.24.4 AccuBioTech Main Business Overview 13.24.5 AccuBioTech Latest Developments 13.25 Assure Tech 13.25.1 Assure Tech Company Information 13.25.2 Assure Tech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.25.3 Assure Tech Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.25.4 Assure Tech Main Business Overview 13.25.5 Assure Tech Latest Developments 13.26 Well Biotech 13.26.1 Well Biotech Company Information 13.26.2 Well Biotech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.26.3 Well Biotech Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.26.4 Well Biotech Main Business Overview 13.26.5 Well Biotech Latest Developments 14 Research Findings and Conclusion
SummaryOral fluid and saliva drug testing are methods used to detect the presence of drugs or their metabolites in a person's saliva. These tests are commonly used in various settings, including workplaces, law enforcement, and clinical environments, due to their non-invasive nature and ease of administration. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Oral Fluid and Saliva Drug Testing Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Oral Fluid and Saliva Drug Testing by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Oral Fluid and Saliva Drug Testing by Country/Region, 2019, 2023 & 2030 2.2 Oral Fluid and Saliva Drug Testing Segment by Type 2.2.1 5 Panels or Less 2.2.2 5 Panel-10 Panel 2.2.3 10 Panels or Above 2.3 Oral Fluid and Saliva Drug Testing Sales by Type 2.3.1 Global Oral Fluid and Saliva Drug Testing Sales Market Share by Type (2019-2024) 2.3.2 Global Oral Fluid and Saliva Drug Testing Revenue and Market Share by Type (2019-2024) 2.3.3 Global Oral Fluid and Saliva Drug Testing Sale Price by Type (2019-2024) 2.4 Oral Fluid and Saliva Drug Testing Segment by Application 2.4.1 Criminal Justice Testing 2.4.2 Workplace Testing 2.4.3 Rehabilitation Therapy 2.4.4 Sports Competition 2.4.5 Others 2.5 Oral Fluid and Saliva Drug Testing Sales by Application 2.5.1 Global Oral Fluid and Saliva Drug Testing Sale Market Share by Application (2019-2024) 2.5.2 Global Oral Fluid and Saliva Drug Testing Revenue and Market Share by Application (2019-2024) 2.5.3 Global Oral Fluid and Saliva Drug Testing Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global Oral Fluid and Saliva Drug Testing Breakdown Data by Company 3.1.1 Global Oral Fluid and Saliva Drug Testing Annual Sales by Company (2019-2024) 3.1.2 Global Oral Fluid and Saliva Drug Testing Sales Market Share by Company (2019-2024) 3.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue by Company (2019-2024) 3.2.1 Global Oral Fluid and Saliva Drug Testing Revenue by Company (2019-2024) 3.2.2 Global Oral Fluid and Saliva Drug Testing Revenue Market Share by Company (2019-2024) 3.3 Global Oral Fluid and Saliva Drug Testing Sale Price by Company 3.4 Key Manufacturers Oral Fluid and Saliva Drug Testing Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Oral Fluid and Saliva Drug Testing Product Location Distribution 3.4.2 Players Oral Fluid and Saliva Drug Testing Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Oral Fluid and Saliva Drug Testing by Geographic Region 4.1 World Historic Oral Fluid and Saliva Drug Testing Market Size by Geographic Region (2019-2024) 4.1.1 Global Oral Fluid and Saliva Drug Testing Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Oral Fluid and Saliva Drug Testing Market Size by Country/Region (2019-2024) 4.2.1 Global Oral Fluid and Saliva Drug Testing Annual Sales by Country/Region (2019-2024) 4.2.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue by Country/Region (2019-2024) 4.3 Americas Oral Fluid and Saliva Drug Testing Sales Growth 4.4 APAC Oral Fluid and Saliva Drug Testing Sales Growth 4.5 Europe Oral Fluid and Saliva Drug Testing Sales Growth 4.6 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales Growth 5 Americas 5.1 Americas Oral Fluid and Saliva Drug Testing Sales by Country 5.1.1 Americas Oral Fluid and Saliva Drug Testing Sales by Country (2019-2024) 5.1.2 Americas Oral Fluid and Saliva Drug Testing Revenue by Country (2019-2024) 5.2 Americas Oral Fluid and Saliva Drug Testing Sales by Type (2019-2024) 5.3 Americas Oral Fluid and Saliva Drug Testing Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Oral Fluid and Saliva Drug Testing Sales by Region 6.1.1 APAC Oral Fluid and Saliva Drug Testing Sales by Region (2019-2024) 6.1.2 APAC Oral Fluid and Saliva Drug Testing Revenue by Region (2019-2024) 6.2 APAC Oral Fluid and Saliva Drug Testing Sales by Type (2019-2024) 6.3 APAC Oral Fluid and Saliva Drug Testing Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Oral Fluid and Saliva Drug Testing by Country 7.1.1 Europe Oral Fluid and Saliva Drug Testing Sales by Country (2019-2024) 7.1.2 Europe Oral Fluid and Saliva Drug Testing Revenue by Country (2019-2024) 7.2 Europe Oral Fluid and Saliva Drug Testing Sales by Type (2019-2024) 7.3 Europe Oral Fluid and Saliva Drug Testing Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Oral Fluid and Saliva Drug Testing by Country 8.1.1 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Country (2019-2024) 8.1.2 Middle East & Africa Oral Fluid and Saliva Drug Testing Revenue by Country (2019-2024) 8.2 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Type (2019-2024) 8.3 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Oral Fluid and Saliva Drug Testing 10.3 Manufacturing Process Analysis of Oral Fluid and Saliva Drug Testing 10.4 Industry Chain Structure of Oral Fluid and Saliva Drug Testing 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Oral Fluid and Saliva Drug Testing Distributors 11.3 Oral Fluid and Saliva Drug Testing Customer 12 World Forecast Review for Oral Fluid and Saliva Drug Testing by Geographic Region 12.1 Global Oral Fluid and Saliva Drug Testing Market Size Forecast by Region 12.1.1 Global Oral Fluid and Saliva Drug Testing Forecast by Region (2025-2030) 12.1.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global Oral Fluid and Saliva Drug Testing Forecast by Type (2025-2030) 12.7 Global Oral Fluid and Saliva Drug Testing Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 Abbott 13.1.1 Abbott Company Information 13.1.2 Abbott Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.1.3 Abbott Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Abbott Main Business Overview 13.1.5 Abbott Latest Developments 13.2 Premier Biotech 13.2.1 Premier Biotech Company Information 13.2.2 Premier Biotech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.2.3 Premier Biotech Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 Premier Biotech Main Business Overview 13.2.5 Premier Biotech Latest Developments 13.3 OraSure Technologies 13.3.1 OraSure Technologies Company Information 13.3.2 OraSure Technologies Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.3.3 OraSure Technologies Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 OraSure Technologies Main Business Overview 13.3.5 OraSure Technologies Latest Developments 13.4 MHE 13.4.1 MHE Company Information 13.4.2 MHE Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.4.3 MHE Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 MHE Main Business Overview 13.4.5 MHE Latest Developments 13.5 VeriCheck 13.5.1 VeriCheck Company Information 13.5.2 VeriCheck Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.5.3 VeriCheck Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 VeriCheck Main Business Overview 13.5.5 VeriCheck Latest Developments 13.6 ulti med Products (Deutschland) 13.6.1 ulti med Products (Deutschland) Company Information 13.6.2 ulti med Products (Deutschland) Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.6.3 ulti med Products (Deutschland) Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 ulti med Products (Deutschland) Main Business Overview 13.6.5 ulti med Products (Deutschland) Latest Developments 13.7 Healgen Scientific 13.7.1 Healgen Scientific Company Information 13.7.2 Healgen Scientific Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.7.3 Healgen Scientific Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Healgen Scientific Main Business Overview 13.7.5 Healgen Scientific Latest Developments 13.8 Alcolizer 13.8.1 Alcolizer Company Information 13.8.2 Alcolizer Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.8.3 Alcolizer Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Alcolizer Main Business Overview 13.8.5 Alcolizer Latest Developments 13.9 CareHealth America 13.9.1 CareHealth America Company Information 13.9.2 CareHealth America Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.9.3 CareHealth America Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 CareHealth America Main Business Overview 13.9.5 CareHealth America Latest Developments 13.10 AlphaBiolabs 13.10.1 AlphaBiolabs Company Information 13.10.2 AlphaBiolabs Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.10.3 AlphaBiolabs Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 AlphaBiolabs Main Business Overview 13.10.5 AlphaBiolabs Latest Developments 13.11 AlcoDigital 13.11.1 AlcoDigital Company Information 13.11.2 AlcoDigital Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.11.3 AlcoDigital Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 AlcoDigital Main Business Overview 13.11.5 AlcoDigital Latest Developments 13.12 Azova 13.12.1 Azova Company Information 13.12.2 Azova Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.12.3 Azova Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.12.4 Azova Main Business Overview 13.12.5 Azova Latest Developments 13.13 Draeger 13.13.1 Draeger Company Information 13.13.2 Draeger Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.13.3 Draeger Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.13.4 Draeger Main Business Overview 13.13.5 Draeger Latest Developments 13.14 Securetec Detektions-Systeme 13.14.1 Securetec Detektions-Systeme Company Information 13.14.2 Securetec Detektions-Systeme Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.14.3 Securetec Detektions-Systeme Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.14.4 Securetec Detektions-Systeme Main Business Overview 13.14.5 Securetec Detektions-Systeme Latest Developments 13.15 Quest Diagnostics 13.15.1 Quest Diagnostics Company Information 13.15.2 Quest Diagnostics Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.15.3 Quest Diagnostics Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.15.4 Quest Diagnostics Main Business Overview 13.15.5 Quest Diagnostics Latest Developments 13.16 Oranoxis 13.16.1 Oranoxis Company Information 13.16.2 Oranoxis Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.16.3 Oranoxis Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.16.4 Oranoxis Main Business Overview 13.16.5 Oranoxis Latest Developments 13.17 Salimetrics 13.17.1 Salimetrics Company Information 13.17.2 Salimetrics Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.17.3 Salimetrics Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.17.4 Salimetrics Main Business Overview 13.17.5 Salimetrics Latest Developments 13.18 Neogen Corporation 13.18.1 Neogen Corporation Company Information 13.18.2 Neogen Corporation Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.18.3 Neogen Corporation Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.18.4 Neogen Corporation Main Business Overview 13.18.5 Neogen Corporation Latest Developments 13.19 UCP Biosciences 13.19.1 UCP Biosciences Company Information 13.19.2 UCP Biosciences Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.19.3 UCP Biosciences Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.19.4 UCP Biosciences Main Business Overview 13.19.5 UCP Biosciences Latest Developments 13.20 Lin-Zhi International 13.20.1 Lin-Zhi International Company Information 13.20.2 Lin-Zhi International Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.20.3 Lin-Zhi International Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.20.4 Lin-Zhi International Main Business Overview 13.20.5 Lin-Zhi International Latest Developments 13.21 MEDACX 13.21.1 MEDACX Company Information 13.21.2 MEDACX Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.21.3 MEDACX Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.21.4 MEDACX Main Business Overview 13.21.5 MEDACX Latest Developments 13.22 MediNat 13.22.1 MediNat Company Information 13.22.2 MediNat Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.22.3 MediNat Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.22.4 MediNat Main Business Overview 13.22.5 MediNat Latest Developments 13.23 WHPM 13.23.1 WHPM Company Information 13.23.2 WHPM Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.23.3 WHPM Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.23.4 WHPM Main Business Overview 13.23.5 WHPM Latest Developments 13.24 AccuBioTech 13.24.1 AccuBioTech Company Information 13.24.2 AccuBioTech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.24.3 AccuBioTech Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.24.4 AccuBioTech Main Business Overview 13.24.5 AccuBioTech Latest Developments 13.25 Assure Tech 13.25.1 Assure Tech Company Information 13.25.2 Assure Tech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.25.3 Assure Tech Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.25.4 Assure Tech Main Business Overview 13.25.5 Assure Tech Latest Developments 13.26 Well Biotech 13.26.1 Well Biotech Company Information 13.26.2 Well Biotech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications 13.26.3 Well Biotech Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024) 13.26.4 Well Biotech Main Business Overview 13.26.5 Well Biotech Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポートLP Information社の医療分野での最新刊レポート本レポートと同じKEY WORD（oral fluid）の最新刊レポートよくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |
